Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

French Registry of Acute Coronary Syndrome (Fast-MI)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
French Cardiology Society
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT00673036
First received: May 5, 2008
Last updated: January 24, 2017
Last verified: October 2016

May 5, 2008
January 24, 2017
October 2005
December 2017   (Final data collection date for primary outcome measure)
All causes mortality at each follow-up period [ Time Frame: 6 months, each year ]
Same as current
Complete list of historical versions of study NCT00673036 on ClinicalTrials.gov Archive Site
  • Cardiovascular mortality [ Time Frame: 6 month, each year ]
  • validation of guidelines across the country [ Time Frame: 6 month, each year ]
  • Pharmacogenetic and cardiovascular genetic studies associated to clinical outcomes [ Time Frame: 6 month each year ]
  • Serum databank for evaluation of biomarkers in MI [ Time Frame: 6 month each year ]
  • Cardiovascular mortality [ Time Frame: 6 month, each year ]
  • validation of guidelines accross the country [ Time Frame: 6 month, each year ]
  • Pharmacogenetic and cardiovascular genetic studies associated to clinical outcomes [ Time Frame: 6 month each year ]
  • Serum databank for evaluation of biomarkers in MI [ Time Frame: 6 month each year ]
Not Provided
Not Provided
 
French Registry of Acute Coronary Syndrome
French Registry of Acute Coronary Syndrome With or Without ST Elevation
The Fast-MI registry was designed to evaluate the "real world" management of patients with acute myocardial infarction (MI), and to assess their in-hospital, medium and long-term outcomes
Primary objectives : compare survival following the admission to a USIC according to the terms of care
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:
Whole blood, serum and DNA
Non-Probability Sample
Admitted patients in a Unit of Coronary Intensive Care (USIC) for a acute coronary syndrome
Acute Myocardial Infarction
Other: Blood sample
60 ml of whole blood
1
Adults (female and male) with a acute coronary syndrome
Intervention: Other: Blood sample

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
3750
June 2019
December 2017   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • admission within the 48 hours after the occurence of acute myocardial infarction (AMI)
  • written informed consent for the DNA and serum databank

Exclusion Criteria:

  • AMI occured within the 48 hours after therapeutic intervention (bypass, coronary angioplasty or other chirurgical intervention)
  • diagnostic of AMI not confirmed
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
France
 
 
NCT00673036
04-1244
No
Not Provided
Not Provided
Not Provided
Assistance Publique - Hôpitaux de Paris
Assistance Publique - Hôpitaux de Paris
French Cardiology Society
Principal Investigator: Nicolas DANCHIN, MD PH Assistance Publique - Hôpitaux de Paris
Assistance Publique - Hôpitaux de Paris
October 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP